The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FIERCE-21: Phase 1b/2 study of docetaxel + b-701, a selective inhibitor of FGFR3, in relapsed or refractory (R/R) metastatic urothelial carcinoma (mUCC).
 
Joaquim Bellmunt
Honoraria - UpToDate
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech; Merck; Novartis; Pfizer; Pierre Fabre
Research Funding - Millennium (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Pfizer
 
Joel Picus
Consulting or Advisory Role - Novo Nordisk
Research Funding - Agensys (Inst); Altor BioScience (Inst); BioClin Therapeutics (Inst); Endocyte (Inst); Innocrin Pharma (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Oncogenex (Inst); Rexahn Pharmaceuticals (Inst); Seagen (Inst)
 
Manish Kohli
No Relationships to Disclose
 
Yull Edwin Arriaga
Consulting or Advisory Role - AstraZeneca; Bayer Health
Speakers' Bureau - Astellas Oncology; AstraZeneca
 
Matthew I. Milowsky
Research Funding - Acerta Pharma (Inst); Agensys (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Graeme Currie
Employment - BioClin Therapeutics; Dynavax Technologies
Leadership - BioClin Therapeutics
Stock and Other Ownership Interests - Dynavax Technologies; Regeneron
Consulting or Advisory Role - Bolt Biotherapeutics; NaNotics
Travel, Accommodations, Expenses - BioClin Therapeutics; Dynavax Technologies
 
Steve Abella
Employment - BioClin Therapeutics; Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Sumanta K. Pal
Honoraria - Astellas Pharma; Medivation; Novartis
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Ipsen; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation